Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Drug Industry"" wg kryterium: Temat


Tytuł :
Executive Order on Ensuring Essential Medicines-All Bark, No Bite?
Autorzy :
Guharoy R; Department of Pharmacy, Baptist Health, Montgomery, AL; Infectious Diseases, University of Massachusetts Medical School, Worcester, MA. Electronic address: .
Noviasky J; Departments of Pharmacy and Medicine, SUNY-Upstate Medical University, Syracuse, NY.
Pokaż więcej
Źródło :
Mayo Clinic proceedings [Mayo Clin Proc] 2021 Jul; Vol. 96 (7), pp. 1714-1717.
Typ publikacji :
Journal Article
MeSH Terms :
Civil Defense*/methods
Civil Defense*/organization & administration
Drug Industry*/organization & administration
Drug Industry*/standards
Drug Industry*/statistics & numerical data
Drugs, Essential*/classification
Drugs, Essential*/economics
Drugs, Essential*/supply & distribution
Strategic Stockpile*/legislation & jurisprudence
Strategic Stockpile*/organization & administration
Surge Capacity*/legislation & jurisprudence
Surge Capacity*/organization & administration
Surge Capacity*/standards
Health Planning/*organization & administration
COVID-19/epidemiology ; Disaster Planning/organization & administration ; Humans ; Legislation, Drug ; Needs Assessment ; SARS-CoV-2 ; United States
Czasopismo naukowe
Tytuł :
Government Pharmaceutical Development to Address High Prices: Challenges Ahead.
Autorzy :
Darrow JJ; Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St., Suite 3030, Boston, MA, 02120, USA. .; Department of Law and Taxation, Bentley University, Waltham, MA, 02452, USA. .
Pokaż więcej
Źródło :
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2021 Sep; Vol. 55 (5), pp. 1103-1105. Date of Electronic Publication: 2021 Jul 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Costs*
Drug Industry*
Costs and Cost Analysis ; Drug Development ; Government ; Humans
Czasopismo naukowe
Tytuł :
Application of Feature Extraction Methods for Chemical Risk Classification in the Pharmaceutical Industry.
Autorzy :
Topolski M; Department of Systems and Computer Networks, Faculty of Electronics, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.
Pokaż więcej
Źródło :
Sensors (Basel, Switzerland) [Sensors (Basel)] 2021 Aug 26; Vol. 21 (17). Date of Electronic Publication: 2021 Aug 26.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Industry*
Principal Component Analysis
Czasopismo naukowe
Tytuł :
Profiteering from vaccine inequity: a crime against humanity?
Autorzy :
Hassan F; Health Justice Initiative, Cape Town, South Africa.
Yamey G; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA.
Abbasi K; The BMJ, London, UK .
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2021 Aug 16; Vol. 374, pp. n2027. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji :
Editorial
MeSH Terms :
Humanities*
COVID-19/*prevention & control
COVID-19 Vaccines/*economics
Drug Industry/*economics
Healthcare Disparities/*economics
COVID-19 Vaccines/supply & distribution ; Crime ; Drug Industry/ethics ; Health Services Accessibility/economics ; Health Services Accessibility/ethics ; Healthcare Disparities/ethics ; Humans ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Analytical techniques currently used in the pharmaceutical industry for the quality control of RNA-based therapeutics and ongoing developments.
Autorzy :
Demelenne A; Laboratory for the Analysis of Medicines, Department of Pharmacy, Center for Interdisciplinary Research on Medicines (CIRM), University of Liege, Quartier Hôpital, Avenue Hippocrate 15, CHU, B36, Liege 4000, Belgium.
Servais AC; Laboratory for the Analysis of Medicines, Department of Pharmacy, Center for Interdisciplinary Research on Medicines (CIRM), University of Liege, Quartier Hôpital, Avenue Hippocrate 15, CHU, B36, Liege 4000, Belgium.
Crommen J; Laboratory for the Analysis of Medicines, Department of Pharmacy, Center for Interdisciplinary Research on Medicines (CIRM), University of Liege, Quartier Hôpital, Avenue Hippocrate 15, CHU, B36, Liege 4000, Belgium.
Fillet M; Laboratory for the Analysis of Medicines, Department of Pharmacy, Center for Interdisciplinary Research on Medicines (CIRM), University of Liege, Quartier Hôpital, Avenue Hippocrate 15, CHU, B36, Liege 4000, Belgium. Electronic address: .
Pokaż więcej
Źródło :
Journal of chromatography. A [J Chromatogr A] 2021 Aug 16; Vol. 1651, pp. 462283. Date of Electronic Publication: 2021 May 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Chemistry, Analytic*
Drug Industry*
RNA, Double-Stranded/*standards
RNA, Double-Stranded/*therapeutic use
Clinical Trials as Topic ; Guidelines as Topic ; Humans ; Quality Control ; RNA, Double-Stranded/chemistry
Czasopismo naukowe
Tytuł :
Transparency Is Not Enough: How Can We Improve the Management of Financial Conflicts of Interest Between Pharma and Healthcare Sectors?
Autorzy :
Ozaki A; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.; Department of Breast Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.
Murayama A; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Saito H; Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Miyagi, Japan.
Sawano T; Department of Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.
Harada K; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Senoo Y; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Yamamoto K; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Tanimoto T; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.; Department of Internal Medicine, Navitas Clinic Kawasaki, Kawasaki, Kanagawa, Japan.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Aug; Vol. 110 (2), pp. 289-291. Date of Electronic Publication: 2020 Dec 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Conflict of Interest*
Drug Industry/*organization & administration
Health Care Sector/*organization & administration
Disclosure/standards ; Drug Industry/standards ; Guidelines as Topic ; Health Care Sector/standards ; Humans
Czasopismo naukowe
Tytuł :
Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective.
Autorzy :
Heimbach T; Pharmaceutical Sciences, Merck & Co., Inc, Rahway, New Jersey, USA.
Chen Y; Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc, South San Francisco, California, USA.
Chen J; Clinical Pharmacology, Alkermes Inc, Waltham, Massachusetts, USA.
Dixit V; Drug Metabolism and Pharmacokinetics, Kymera Therapeutics, Watertown, Massachusetts, USA.
Parrott N; Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Peters SA; Translational Medicine, Merck Healthcare KGaA, Darmstadt, Germany.
Poggesi I; Clinical Pharmacology and Pharmacometrics, Janssen, Milan, Italy.
Sharma P; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK.
Snoeys J; Department of Drug Metabolism and Pharmacokinetics, Janssen R&D, Beerse, Belgium.
Shebley M; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, Illinois, USA.
Tai G; Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Plc, Collegeville, Pennsylvania, USA.
Tse S; Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc, Groton, Connecticut, USA.
Upreti VV; Clinical Pharmacology, Modeling & Simulation, Amgen Inc, South San Francisco, California, USA.
Wang YH; Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co, Inc, Kenilworth, New Jersey, USA.
Tsai A; Department of Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals Inc, Boston, Massachusetts, USA.
Xia B; PK/PD Group, Pharmacokinetics, Dynamics and Metabolism, Sanofi, Bridgewater, New Jersey, USA.
Zheng M; Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb, Princeton, New Jersey, USA.
Zhu AZX; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International, Co, Cambridge, Massachusetts, USA.
Hall S; Department of Drug Disposition, Lilly, Indianapolis, Indiana, USA.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Aug; Vol. 110 (2), pp. 297-310. Date of Electronic Publication: 2020 Dec 30.
Typ publikacji :
Journal Article
MeSH Terms :
Models, Biological*
Pharmacokinetics*
Drug Industry/*organization & administration
Kidney Diseases/*metabolism
Liver Diseases/*metabolism
Area Under Curve ; Computer Simulation ; Dose-Response Relationship, Drug ; Drug Industry/standards ; Humans ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Multivariate Spectroscopic Method Lifecycle Management as Part of the Quality Management System.
Autorzy :
Igne B; Analytical Development, Vertex Pharmaceuticals Inc., Boston, MA, USA. Electronic address: .
Liu Y; Pfizer, Worldwide Research and Development, Analytical R&D, Groton, CT, USA.
Shi Z; Lilly Research Laboratory, Eli Lilly and Company, Indianapolis, IN, USA.
Alam MA; Pfizer, Worldwide Research and Development, Analytical R&D, Groton, CT, USA.
Garrett A; Global Quality Laboratory, Eli Lilly and Company, Indianapolis, IN, USA.
Daughtry S; Analytical Development, Vertex Pharmaceuticals Inc., Boston, MA, USA.
Liesum L; Roche, Pharma Technical Innovation, F. Hoffmann- La Roche Ltd, 4070 Basel, Switzerland.
Nielsen S; Janssen Supply Chain, Johnson & Johnson, New Brunswick, NJ, USA.
Pokaż więcej
Źródło :
Journal of pharmaceutical sciences [J Pharm Sci] 2021 Aug; Vol. 110 (8), pp. 2925-2933. Date of Electronic Publication: 2021 Mar 27.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Development*
Drug Industry*
Quality Control ; Spectrum Analysis ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Why are certain age bands used for children in paediatric studies of medicines?
Autorzy :
Hoppu K; New Children's Hospital, Helsinki University Hospital, Helsinki, Finland .; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
Fonseca H; Adolescent Outpatient Clinic, Department of Paediatrics, Hospital de Santa Maria, Lisbon, Portugal.; Paediatric Committee (PDCO), European Medicines Agency, Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
Archives of disease in childhood [Arch Dis Child] 2021 Jul; Vol. 106 (7), pp. 631-635. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji :
Historical Article; Journal Article; Review
MeSH Terms :
Drug Approval/*legislation & jurisprudence
Drug Industry/*ethics
Legislation, Drug/*statistics & numerical data
Pharmaceutical Preparations/*history
Adolescent ; Age Factors ; Child ; Child, Preschool ; Drug Development/legislation & jurisprudence ; Drug Industry/legislation & jurisprudence ; Drug Labeling/legislation & jurisprudence ; Drug Labeling/statistics & numerical data ; Drug Prescriptions ; Guidelines as Topic ; History, 19th Century ; Humans ; Infant ; Infant, Newborn
Czasopismo naukowe
Tytuł :
The effect of generic market entry on antibiotic prescriptions in the United States.
Autorzy :
Kållberg C; Faculty of Medicine, Institute of Health and Society, University of Oslo, Oslo, Norway. .; Norwegian Institute of Public Health, Oslo, Norway. .
Hudson J; Health Services Research Unit, University of Aberdeen, Aberdeen, UK.
Salvesen Blix H; Norwegian Institute of Public Health, Oslo, Norway.; School of Pharmacy, University of Oslo, Oslo, Norway.
Årdal C; Norwegian Institute of Public Health, Oslo, Norway.
Klein E; Center for Disease Dynamics, Economics and Policy, Washington, DC, USA.; Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Lindbæk M; Faculty of Medicine, Institute of Health and Society, University of Oslo, Oslo, Norway.
Outterson K; School of Law, Boston University, Boston, MA, USA.; CARB-X, Boston, MA, USA.
Røttingen JA; Faculty of Medicine, Institute of Health and Society, University of Oslo, Oslo, Norway.; Norwegian Institute of Public Health, Oslo, Norway.; The Research Council of Norway, Lysaker, Norway.
Laxminarayan R; Center for Disease Dynamics, Economics and Policy, Washington, DC, USA.; Princeton University, Princeton, NJ, USA.
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 May 18; Vol. 12 (1), pp. 2937. Date of Electronic Publication: 2021 May 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Drug Costs/*statistics & numerical data
Drug Industry/*statistics & numerical data
Drug Prescriptions/*statistics & numerical data
Drugs, Generic/*therapeutic use
Anti-Bacterial Agents/classification ; Anti-Bacterial Agents/economics ; Aztreonam/economics ; Aztreonam/therapeutic use ; Cefdinir/economics ; Cefdinir/therapeutic use ; Cephalosporins/economics ; Cephalosporins/therapeutic use ; Costs and Cost Analysis ; Databases, Pharmaceutical/statistics & numerical data ; Drug Industry/economics ; Drug Industry/trends ; Drugs, Generic/classification ; Drugs, Generic/economics ; Humans ; United States
Czasopismo naukowe
Tytuł :
Bachem - Insights into Innovative and Sustainable Peptide Chemistry and Technology by the Leading Independent Manufacturer of TIDES.
Autorzy :
Jadhav S; Bachem AG, Hauptstrasse 144, CH-4416 Bubendorf, Switzerland.
Seufert W; Bachem AG, Hauptstrasse 144, CH-4416 Bubendorf, Switzerland.
Lechner C; Bachem AG, Hauptstrasse 144, CH-4416 Bubendorf, Switzerland.
Schönleber R; Bachem AG, Hauptstrasse 144, CH-4416 Bubendorf, Switzerland;, Email: .
Pokaż więcej
Źródło :
Chimia [Chimia (Aarau)] 2021 Jun 30; Vol. 75 (6), pp. 476-479.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Industry*
Pharmaceutical Preparations*
Peptides ; Quality Control
Czasopismo naukowe
Tytuł :
[Teaching conflicts of interest with industry as a « role model »].
Autorzy :
Aebischer G; Institut universitaire de médecine de famille et de l'enfance, Faculté de médecine, Université de Genève, 1211 Genève 4.
Sommer J; Institut universitaire de médecine de famille et de l'enfance, Faculté de médecine, Université de Genève, 1211 Genève 4.
Pokaż więcej
Transliterated Title :
Enseigner les conflits d’intérêts avec l’industrie – l’importance du « modèle de rôle ».
Źródło :
Revue medicale suisse [Rev Med Suisse] 2021 May 12; Vol. 17 (738), pp. 912-914.
Typ publikacji :
Journal Article
MeSH Terms :
Conflict of Interest*
Drug Industry*
Gift Giving ; Humans ; Teaching
Czasopismo naukowe
Tytuł :
Industry-Sponsored Speaker Programs-End of the Line?
Autorzy :
Adashi EY; Brown University, Providence, Rhode Island.
Cohen IG; Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School, Harvard University, Cambridge, Massachusetts.
Pokaż więcej
Źródło :
JAMA [JAMA] 2021 May 11; Vol. 325 (18), pp. 1835-1836.
Typ publikacji :
Journal Article
MeSH Terms :
Conflict of Interest*/legislation & jurisprudence
Ethics, Medical*
Drug Industry/*legislation & jurisprudence
Education, Medical, Continuing/*ethics
Fraud/*legislation & jurisprudence
Drug Industry/ethics ; Fraud/ethics ; Industry/ethics ; Industry/legislation & jurisprudence ; United States
Czasopismo naukowe
Tytuł :
Incentives to promote the US pharmaceutical innovation: empirical research based on the case of Epogen.
Autorzy :
Zhang L; School of Management, Shanghai University, Shanghai, China.
Wang J; School of Management, Shanghai University, Shanghai, China.
Pokaż więcej
Źródło :
Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2021 May; Vol. 47 (5), pp. 820-824. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Industry*
Pharmaceutical Preparations*
Empirical Research ; Epoetin Alfa ; Motivation ; Retrospective Studies ; United States
Czasopismo naukowe
Tytuł :
Are academia-pharma partnerships essential for novel drug discovery in the time of the COVID-19 pandemic?
Autorzy :
Lexchin J; Professor Emeritus, School of Health Policy and Management, York University, Toronto, ON, Canada.; Associate Professor, Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.; Emergency Physician, University Health Network, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Expert opinion on drug discovery [Expert Opin Drug Discov] 2021 May; Vol. 16 (5), pp. 475-479. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji :
Editorial
MeSH Terms :
Academic Medical Centers*
Drug Discovery*
Drug Industry*
Public-Private Sector Partnerships*
Research Support as Topic*
Universities*
Adenosine Monophosphate/analogs & derivatives ; Alanine/analogs & derivatives ; Antiviral Agents ; Bias ; COVID-19/drug therapy ; COVID-19/prevention & control ; COVID-19 Vaccines ; Humans ; Research ; SARS-CoV-2
SCR Protocol :
COVID-19 drug treatment
Opinia redakcyjna
Tytuł :
Prescribers Perception on Drug Promotional Literatures in A Tertiary Care Hospital in Nepal.
Autorzy :
Prasad P; Department of Clinical Pharmacology, Maharajgunj Medical Campus, Maharajgunj, Kathmandu.
Mudvari A; Department of Clinical Pharmacology, Maharajgunj Medical Campus, Maharajgunj, Kathmandu.
Ghimire R; Department of Clinical Pharmacology, Maharajgunj Medical Campus, Maharajgunj, Kathmandu.
Karki N; Department of Pharmacology, Lumbini Medical College and Teaching Hospital, Pravas, Palpa.
Yadav D; Department of Clinical Pharmacology, Maharajgunj Medical Campus, Maharajgunj, Kathmandu.
Shah S; Department of Community Medicine, Kathmandu Medical College and Teaching Hospital Pvt. Ltd., Sinamangal, Kathmandu, Nepal.
Gyanwali P; Department of Clinical Pharmacology, Maharajgunj Medical Campus, Maharajgunj, Kathmandu.
Pokaż więcej
Źródło :
Journal of Nepal Health Research Council [J Nepal Health Res Counc] 2021 Apr 23; Vol. 19 (1), pp. 19-25. Date of Electronic Publication: 2021 Apr 23.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Industry*
Pharmaceutical Preparations*
Cross-Sectional Studies ; Humans ; Nepal ; Perception ; Tertiary Care Centers
Czasopismo naukowe
Tytuł :
Analytical Method Lifecycle Management in Pharmaceutical Industry: a Review.
Autorzy :
Volta E Sousa L; Analytical Development, R&D, Hovione FarmaCiência S.A, Campus do Lumiar, Edifício R, Estrada do Paço do Lumiar, 1649-038, Lisboa, Portugal. .
Gonçalves R; Analytical Development, R&D, Hovione FarmaCiência S.A, Campus do Lumiar, Edifício R, Estrada do Paço do Lumiar, 1649-038, Lisboa, Portugal.
Menezes JC; Institute for Biotechnology and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Avenida Av. Rovisco Pais, 1, 1049-001, Lisbon, Portugal.
Ramos A; Analytical Development, R&D, Hovione FarmaCiência S.A, Campus do Lumiar, Edifício R, Estrada do Paço do Lumiar, 1649-038, Lisboa, Portugal.
Pokaż więcej
Źródło :
AAPS PharmSciTech [AAPS PharmSciTech] 2021 Apr 09; Vol. 22 (3), pp. 128. Date of Electronic Publication: 2021 Apr 09.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Industry/*standards
Pharmaceutical Preparations/*analysis
Chemistry, Pharmaceutical ; Drug Design ; Drug Industry/trends ; Humans ; Quality Control
Czasopismo naukowe
Tytuł :
Paediatric Medicines - Regulatory Drivers, Restraints, Opportunities and Challenges.
Autorzy :
Vieira I; Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.
Sousa JJ; Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; Coimbra Chemistry Centre, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal.
Vitorino C; Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; Coimbra Chemistry Centre, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal; Centre for Neurosciences and Cell Biology (CNC), University of Coimbra, Faculty of Medicine, Rua Larga, Pólo I, 1st Floor, 3004-504 Coimbra, Portugal. Electronic address: .
Pokaż więcej
Źródło :
Journal of pharmaceutical sciences [J Pharm Sci] 2021 Apr; Vol. 110 (4), pp. 1545-1556. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Drug Industry*
Pharmaceutical Preparations*
Child ; Humans ; United States ; United States Food and Drug Administration
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies